Reju Korah

Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas.

Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow.

Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells.

Flavopiridol blocks integrin-mediated survival in dormant breast cancer cells.

Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium.

Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.

Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.

Quantitative assessment of RASSF1A methylation as a putative molecular marker in papillary thyroid carcinoma.

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.

Gene expression and regulation in adrenocortical tumorigenesis.

Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.

Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas.

TERT promoter mutations are rare in parathyroid tumors.

Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene.

Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.

Chromosome 19 amplification correlates with advanced disease in adrenocortical carcinoma.

DNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinoma.

Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.

A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.

DNA Mismatch Repair Deficiency Promotes Genomic Instability in a Subset of Papillary Thyroid Cancers.

Mutational Analysis ofin Sporadic Parathyroid Adenomas.

BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.

Whole-Exome Sequencing Identifies Two Discrete Druggable Signaling Pathways in Follicular Thyroid Cancer.